Get startedLog in
    Picture of Shenzhen Hepalink Pharmaceutical Co logo

    9989 — Shenzhen Hepalink Pharmaceutical Co News Story

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareAdventurousMid CapNeutral
    All News

    Brief: OrbiMed Capital's Long Position In H-Shares Of Hepalink Pharmaceutical Falls To 4.83% - Filing

    Picture of Shenzhen Hepalink Pharmaceutical Co logoShenzhen Hepalink Pharmaceutical Co
    21/11/2022 09:08
    Nov 21 (Reuters) - Hong Kong stock exchange filing:
    * ORBIMED CAPITAL LLC'S LONG POSITION IN H-SHARES OF
SHENZHEN
HEPALINK PHARMACEUTICAL  9989.HK  REDUCED TO 4.83% ON NOV 15
FROM 5.37% - HKEX FILING

    Source text
  
Further company coverage:  9989.HK 
 (Reporting by Hong Kong newsroom)
 ((twinnie.siu@tr.com; 852-3462 7715;))

    Recent news on Shenzhen Hepalink Pharmaceutical Co

    See all news